PCK 0.00% 3.1¢ painchek ltd

PainChek General Discussion, page-20318

  1. 388 Posts.
    lightbulb Created with Sketch. 85
    Wanted to point out that there is +25% jump in assessments in the cumulative assessments from Q4-22 into Q1-23... 2.0m vs 2.5m.

    This is +500K assessments (Linkedin post) in the latest quarter vs historical of ~ +300K per quarter.. if anything this is suggesting clinical pull through... which is probably a leading indicator of product acceptance and change in industry behaviour...
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.